[塞特拉林诱发的急性乙性肺炎:当副作用成为临床病例时]
L Brichard1, C Stavart2, J El Hayeck1
1Département de pédiatrie, CHU UCL Namur (site de Dinant), 5500 Dinant, Belgique.
Revue des maladies respiratoires
|June 20, 2025
概括
急性埃索诺菲尔性肺炎是塞特拉林的一种罕见副作用. 这份病例报告强调了对这种严重的抗抑郁药副作用的及时诊断和管理,特别是在青少年中.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 青少年健康 青少年健康
背景情况:
- 异性肺部疾病涉及异性肺部组织的透.
- 急性乙性肺炎 (AEP) 是一种严重的,罕见的形式,经常被误认为是传染性肺炎.
- AEP的触发因素包括吸烟,药物和异常因素,其中包括塞特拉林.
研究的目的:
- 在青少年中报告塞特拉林诱导的急性埃索诺菲尔肺炎病例.
- 为了强调认识到罕见抗抑郁药副作用的重要性.
- 为了突出在青少年中非标签使用塞特拉林的考虑因素.
主要方法:
- 一个15岁的女性出现呼吸系统症状的病例报告.
- 病史包括使用塞特拉林治疗和吸烟.
- 诊断工作包括胸部成像和支气管支气管淋浴 (BAL).
主要成果:
- BAL显示了显著增加的乙素细胞计数.
- 停止使用塞特拉林和皮质类固醇治疗导致临床改善.
- 患者的症状在干预后得到缓解.
结论:
- 塞特拉林可以诱导急性乙性肺炎,这是一个罕见但严重的不良反应.
- 早期识别和管理对于有利的结果至关重要.
- 建议在给青少年开处方时谨慎使用塞特拉林非标签,特别是考虑到越来越多的心理健康问题.
相关概念视频
Pneumonia I: Introduction
345
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
Antiasthma Drugs: Leukotriene Modifiers
502
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
502
Pneumonia III: Complications and Assessment
455
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
455
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Pneumonia II: Pathophysiology
617
The pathophysiology of pneumonia involves the following steps:
617
Pneumonia IV: Management
458
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
458


